AAP Leader Saurabh Bharadwaj Questions India’s Use of Covishield Amid Global Withdrawal

AAP Leader Saurabh Bharadwaj Questions India's Use of Covishield Amid Global Withdrawal/ANI

VoM News Desk | May 8, 2024 | 10:41 AM IST | India, Politics | Follow on Google News

AAP Leader Saurabh Bharadwaj Questions India’s Use of Covishield Amid Global Withdrawal

AAP Leader Saurabh Bharadwaj Questions India’s Use of Covishield Amid Global Withdrawal

After AstraZeneca’s COVID-19 vaccine was withdrawn worldwide, AAP leader Saurabh Bharadwaj questioned India’s decision to allow Covishield despite European bans due to side effects. The withdrawal came after AstraZeneca acknowledged a rare and dangerous side effect, prompting removal for commercial reasons.

AstraZeneca stated that the vaccine, superseded by updated versions, was no longer being manufactured or supplied. Despite rare blood clot concerns, the company maintained the decision to withdraw wasn’t related to recent court admissions. Regulatory agencies continue to advocate for vaccination, citing its overall safety profile and benefits outweighing risks.

S9urce: ANI

VoM News Desk

VoM News is an online web portal in jammu Kashmir offers regional, National & global news.